Sun Pharma shares extend 4-day rally after USFDA approval for ILUMYA in arthritis patients

Sun Pharmaceutical Industries Ltd. received US FDA approval for ILUMYA to treat adults with active psoriatic arthritis, expanding its use from plaque psoriasis.